Drug intelligence / Profile preview

galacto-xyloglucan

Development stage
Unknown
Modality
Nanoparticles → Drug Delivery Systems
Administration
Ophthalmic, Intravenous, Oral
01

Overview

Galacto-xyloglucan is a natural glucose polymer derived from the seeds of *Tamarindus indica*. It features branched side chains due to the insertion of xylose residues, which can be further linked to galactose and fucose. This unique structure allows it to mimic the natural mucosal barrier, providing protective effects on epithelial surfaces by limiting the entry of harmful agents. Galacto-xyloglucan is primarily used as a mucoadhesive agent in ophthalmic formulations for dry eye disease and has also been investigated as an immunostimulatory agent with selective cytotoxicity against cancer cells. In combination with hyaluronic acid, it demonstrates synergistic protective effects on the ocular surface and improves symptoms associated with dry eye disease[1][2][5]. As a drug delivery vehicle (e.g., in nanoparticle form), it enhances targeted delivery and cytotoxicity of chemotherapeutics like doxorubicin while sparing normal cells[2].

Brand names
VISINE INTENSIV 1% EDO
Other names
galactoxyloglucantamarind seed polysaccharidePST001PST-001PST 001
02

Targets

MUC (Mucin family)

Beyond the preview

Go deeper on galacto-xyloglucan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on galacto-xyloglucan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call